• Building Intentions with the Theory of Planned Behaviour- The Mediating Role of Knowledge and Expectations in Successful New Pharmacy Public Health Services Implementation

    Nov 1, 2016, 00:00
  • Matching Adjusted Indirect Comparison (MAIC) Analysis For Ponatinib Vs Bosutinib In Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)

    Nov 1, 2016, 00:00
  • Cost Of Illness Of Partial Onset Seizures Epilepsy In Italy- Results From The Prometeo Study

    Nov 1, 2016, 00:00
  • The Burden Associated with Intra-Operative Anastomotic Leaks in Colorectal Surgery

    Nov 1, 2016, 00:00
  • Risk Factors Influencing Cardiovascular Disease in Indian Women with Type 2 Diabetes Mellitus- A Retrospective Case-Control Study

    Nov 1, 2016, 00:00
  • Antiviral Activity and Embryonic Toxicity of Moxidectin Against Influenza Virus H9

    Nov 1, 2016, 00:00
  • Is There a Threshold in France?- First Exhaustive Review of Published Health-Economic Appraisals by the Haute Autorite De Sante (HAS), (French National Authority for Health)

    Nov 1, 2016, 00:00
  • Optimising Adverts And Campaigns For Efficient And Cost-Effective Patient Recruitment Using Social Media

    Nov 1, 2016, 00:00
  • A Cost Comparison of 1l Treatment Regimens for Metastatic Colorectal Cancer (MCRC) in Italy

    Nov 1, 2016, 00:00
  • Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study

    Nov 1, 2016, 00:00
  • Rapid, Comprehensive Oral Nutritional Supplement Quality Improvement Program Reduces Length Of Stay In Malnourished Hospitalized Patients

    Nov 1, 2016, 00:00
  • A Critical Review of Medication Review Tools for Long-Term Care Facilities and Development of a Novel Tool for Qatar

    Nov 1, 2016, 00:00
  • Cost-Effectiveness Analysis of Screening Strategies for Atrial Fibrillation in England and Wales

    Nov 1, 2016, 00:00
  • Reform of Chinese State-Owned Enterprise-Affiliated Hospital

    Nov 1, 2016, 00:00
  • Improving Patients Quality of Life By Valuation of Patient Satisfaction with Specific Characteristics of Medical Devices For Urinary Incontinence

    Nov 1, 2016, 00:00
  • A Decision-Focused Network Meta-Analysis (NMA) of Dipeptidyl Peptidase-4 (DPP4) Inhibitors Used In Combination With Metformin And A Sulfonylurea For The Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00
  • The Nice Accelerated Access Review, How Does it Compare to The Dutch Conditional Reimbursement Pathway?

    Nov 1, 2016, 00:00
  • Real World Anaplastic Lymphoma Kinase (ALK) Rearrangement Testing Patterns, Treatment Sequences and Survival of ALK-Inhibitor Treated Patients

    Nov 1, 2016, 00:00
  • Comparative Safety and effectiveness of Carbapenems Versus Alternative Antibiotics for Bacteraemia due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Empirical Therapy- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00
  • Value And Cost Conundrum In Advanced Oncology- Integration Of Value Frameworks Into Cost-Effectiveness Analyes

    Nov 1, 2016, 00:00
  • Access To Orphan Drugs In Poland - Is Change In Health Technology Assessment Approach Required?

    Nov 1, 2016, 00:00
  • Title- Access to Orphan and Ultra-Orphan Drugs in China

    Nov 1, 2016, 00:00
  • The Implications of Parameter Independence in Probabilistic Sensitivity Analysis

    Nov 1, 2016, 00:00
  • Validation of A Novel Tool To Predict Outcomes in Patients with Nosocomial Pneumonia

    Nov 1, 2016, 00:00
  • Spinal Cord Stimulation Versus Conventional Medical Management for Failed Back Surgery Syndrome- A Dutch Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00
  • Pretesting An E-Based Version Of The Oxford Participation Activities Questionnaire (Ox-Paq)

    Nov 1, 2016, 00:00
  • Disease Activity, Quality of Life And Indirect Costs Associated With Ulcerative Colitis In Poland

    Nov 1, 2016, 00:00
  • Structure of HTA Networks From The Perspective of Network Economics

    Nov 1, 2016, 00:00
  • Impact of Glucosamin and Chondroitin Sulfates Combination (GCSC) on the Burden of Osteorthritis over 6 Months in Portugal- An Observational Study

    Nov 1, 2016, 00:00
  • Does The Trend Towards Value Frameworks Require New Approaches to Evidence Development and Health Technology Assessment?

    Nov 1, 2016, 00:00
  • Network Analysis Approach To Explore Sponsor Involvement In Clinical Trials

    Nov 1, 2016, 00:00
  • Work Productivity/Interference and General Health Status Improvements with Sirukumab, an Anti-Il-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Treatment with Disease-Modifying Anti-Rheumatic Drugs- Res ...

    Nov 1, 2016, 00:00
  • Demographic and Clinical Characteristics of Migraine Patients in Denmark

    Nov 1, 2016, 00:00
  • Assessment of Health Related Quality of Life (Hrqol) of Patients with Severe Mental Illness Attending Tertiary Care Public Hospitals of Quetta, Pakistan

    Nov 1, 2016, 00:00
  • Azacitidine for Treating Acute Myeloid Leukaemia- A Nice Single Technology Appraisal

    Nov 1, 2016, 00:00
  • Budget Impact Analysis of Triveram for The Treatment of Hypertension in Italy

    Nov 1, 2016, 00:00
  • Reconstruction Of Major Lower-Extremity Amputation Stump With A Free Latissimus Dorsi Flap

    Nov 1, 2016, 00:00
  • Creating Useful and Comprehensive Decision Support Tools for Selecting and Designing Managed Entry Agreements

    Nov 1, 2016, 00:00
  • Patient-Reported Need vs. Concern Around Injectable Therapy and Impact on Adheren A Real-World Survey of 5EU/US T2DM Patients

    Nov 1, 2016, 00:00
  • Economic Burden Associated with Chronic Myeloid Leukemia (CML) Treatments in The United States- A Systematic Literature Review

    Nov 1, 2016, 00:00
  • The Impact of Community Pharmacies (CP) On Regional Equity In The Access To The Portuguese Needle And Exchange Programme (NEP)

    Nov 1, 2016, 00:00
  • Identifying Patient Reported Signs and Symptoms of Being Overweight and Obese

    Nov 1, 2016, 00:00
  • Online Pharmacy Regulation in India- A Cross Sectional Survey on Perceptions of Health Care Students/Professionals

    Nov 1, 2016, 00:00
  • Assessing The Consequences Of Sustained Off-Therapy Hbsag Loss In Health Economic Models Of Chronic Hepatitis B; A Systematic Literature Review

    Nov 1, 2016, 00:00
  • Budget Impact Analysis for Intracameral Injectable Solution Combining Two Mydriatics and One Anaesthetic for Cataract Surgery

    Nov 1, 2016, 00:00
  • Predictors of Disease Progression in Mild Alzheimer’s Disease Dementia Patients – Results From the Geras Real World Cohort and Expedition Trials

    Nov 1, 2016, 00:00
  • New Legislative Pathway of Turkey for Assessing Reimbursement Applicatons of Medical Devices

    Nov 1, 2016, 00:00
  • Determination Of Clinical And Cost-Effectiveness Of Various Methods Of Predicting Preterm Birth In Women With High Risk

    Nov 1, 2016, 00:00
  • Clinical And Econimic Burden Of Community-Onset Complicated Skin And Skin Structure Infection (Csssi) In Korea

    Nov 1, 2016, 00:00
  • Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In Slovenia

    Nov 1, 2016, 00:00
  • Health Technology Assessment Decisions for Novel Psoriasis and Psoriatic Arthritis Agents- Results, Rationale, and Trends

    Nov 1, 2016, 00:00
  • Cost-Effectiveness Analysis of Long-Term Versus Short-Term Dual Antiplatelet Therapy in Patients with Drug-Eluting Stents

    Nov 1, 2016, 00:00
  • Development of An Economic Model To Assess The Cost-Effectiveness of Nitisinone As A Treatment For Alkaptonuria In The UK

    Nov 1, 2016, 00:00
  • A Comparison of Insulin Degludec Clinical Evaluations and Recommendations Between an Independent HTA and National HTA Bodies

    Nov 1, 2016, 00:00
  • Seasonal Variations of Outpatient Antibiotic use in Austria

    Nov 1, 2016, 00:00
  • A Qualitative Study Exploring Perception and Attitudes of Community Pharmacists About Extended Pharmacy Services in Lahore, Pakistan

    Nov 1, 2016, 00:00
  • The Health And Economic Burden of Obesity In Chile – An Epidemiological And Economic Simulation Model

    Nov 1, 2016, 00:00
  • Cost–Effectiveness of Different Strategies for Prevention of Venous Thromboembolism after Total Hip Replacement in China

    Nov 1, 2016, 00:00
  • Linguistic Validation of the Finnish Version of the Body-Q Pro Instrument

    Nov 1, 2016, 00:00
  • Treatment of Hypertension in Elderly - Pharmacoeconomic Evaluation

    Nov 1, 2016, 00:00
  • Reweighting Rct Evidence To Better Reflect Real Life- A Case Study of The Innovation Medicines Initiative

    Nov 1, 2016, 00:00
  • Effects of A Chronic Obstructive Pulmonary Disease Integrated Care Pathway Programme in Singapore

    Nov 1, 2016, 00:00
  • A Synopsis on Opportunities and Challenges of Patient Related Outcome Measures (PROMS) for Patient Benefits

    Nov 1, 2016, 00:00
  • Role of Genetic Variation in Type Repeats of Histidine Rich Protein-2 Gene in Altering the Performance of Malaria Rapid Detection Kit in Global Context

    Nov 1, 2016, 00:00
  • Physicians’ Behavior Influences the Health and Economic Impact of Applying Circulating Tumor Cells as Response Marker in Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2016, 00:00
  • Comparison Between Eq-5d And Hui In Japanese Population Norms

    Nov 1, 2016, 00:00
  • Social Preferences for Rare Diseases in Spain

    Nov 1, 2016, 00:00
  • Factors Affecting Pharmaceutical Expenditures- A Systematic Review

    Nov 1, 2016, 00:00
  • Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In Europe

    Nov 1, 2016, 00:00
  • Cost of Switching From An Originator Biologic (Remicade) To A Biosimilar

    Nov 1, 2016, 00:00
  • A Population-Based Cohort of Gaucher Disease Patients Identified Using EHR Data

    Nov 1, 2016, 00:00
  • The Burden of Illness in Patients with Castrate-Resistant Prostate Cancer with Bone Metastases in Asia Pacific (Australia, South Korea, and Taiwan)

    Nov 1, 2016, 00:00
  • The Role of Economic Evidence in Drug Reimbursement- South Korea

    Nov 1, 2016, 00:00
  • How do Cost-Containment Measures Impact Pharmaceutical Industry?

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Different Cervical Cancer Primary Screening Using Cytology, HPV Or P16/KI-67 Testing Alone Or in Combinations for The Austrian Health Care Context

    Nov 1, 2016, 00:00
  • Do Scottish Formulary Decisions Match Recommendations Made By The Smc?

    Nov 1, 2016, 00:00
  • Clinical Effectiveness of Carbapenem Versus Alternative Antibiotics For Urinary Tract Infection Due to Enterobacteriaceae Producing Esbl- A Systmatic Review

    Nov 1, 2016, 00:00
  • Assessment of Knowledge, Attitude and Barriers Towards ADRS Reporting Among Healthcare Professionals of Abbottabad, Pakistan

    Nov 1, 2016, 00:00
  • Use Of Surveillance Databases To Describe Influenza Epidemiology In Europe

    Nov 1, 2016, 00:00
  • The Impact of Underusing Lipid-Lowering Medications on the Risk of Heart Attack and Hospitalizations in United States Elderly Population

    Nov 1, 2016, 00:00
  • Improving Patients Quality of Life By Valuation of Patient Satisfaction With Specific Characteristics of Rehabilitation Medical Devices - Weight, Fit, Appearance, Comfort, Pain Free, Free of Abrasiveness, Ease of Application And Durability

    Nov 1, 2016, 00:00
  • Influence of Air Pollution on Some Pregnancy Outcomes and Burden of Pneumonia on Children Under Five Years Old in Mongolia

    Nov 1, 2016, 00:00
  • Levonorgestrel Intrauterine System And Norethisterone For The Treatment of Chronic Abnormal Uterine Bleeding- A Randomized Clinical Comparison In The Patients of Bahawalpur, Pakistan

    Nov 1, 2016, 00:00
  • Productivity Loss of Cancer Patients in Japan

    Nov 1, 2016, 00:00
  • Utilization of Antimicrobial Agents at the Haematology Ward in a Public Hospital

    Nov 1, 2016, 00:00
  • Hospital Admissions and Inpatient Costs of Non-Union, Delayed Union and Mal-Union Following Long Bone Fracture

    Nov 1, 2016, 00:00
  • Patience is a Virtue When Connecting Evidence Networks

    Nov 1, 2016, 00:00
  • The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in England and Scotland- Applying Real-World Evidence to Enhance Generalisability to A UK Population

    Nov 1, 2016, 00:00
  • Progression and Outcomes of Non-Dialysis Dependent Chronic Kidney Disease Patients

    Nov 1, 2016, 00:00
  • The Budget Impact Analysis of Thrombopoietin Receptor Agonists For The Treatment of Idiopathic Thrombocytopenic Purpura In Adults

    Nov 1, 2016, 00:00
  • Determination of Serum Carbamazepine Concentration Using Dried Blood Spot Specimens for Resource Limited Settings

    Nov 1, 2016, 00:00
  • Measurement of Utilities by Time to Death Related to Advanced Non-Small Cell Lung Cancer in South Korea

    Nov 1, 2016, 00:00
  • Prevalence of Low Birthweight and its Correlates from 2008 to 2014 in Xindu County of Chengdu, China

    Nov 1, 2016, 00:00
  • Real-World Evidence in the Context of Hta- On the Example of Uterine Fibroids Treatment in Ukraine

    Nov 1, 2016, 00:00
  • Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Screening Program

    Nov 1, 2016, 00:00
  • The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in Alternative Age Groups

    Nov 1, 2016, 00:00
  • Valuation of EQ-5D-5L Health States- A Comparison of Three Asian Countries

    Nov 1, 2016, 00:00
  • Variations in Stakeholder Preferences between Innovative Pricing Agreement Types Across the EU5

    Nov 1, 2016, 00:00
  • An International Patient Survey on Health Related Quality of Life Aspects not Cpatured by EQ-5D-5L

    Nov 1, 2016, 00:00
  • The impact of Local Skin Reactions (LSRS) on Resource Use and Quality of Life Associated with Different Field Therapies for Actinic Keratosis. Results from a Belgian Expert Survey

    Nov 1, 2016, 00:00
  • Health State Utility Values (Hsuvs) Measured Using The Euroqol 5-Dimensions (Eq-5d) Questionnaire In Adults With Chronic Hepatitis C (Chc)- A Systematic Literature Review (Slr)

    Nov 1, 2016, 00:00
  • TBO-Filgrastim Patterns of Care by Treatment Site and Setting in The United States, 2014 and 2015

    Nov 1, 2016, 00:00
  • Cost-Effective Analysis Of The Dengue Vaccine In Costa Rica

    Nov 1, 2016, 00:00
  • Clinical Profile and Management of Chronic Kidney Disease in Indian Geriatric Patients at a Public Tertiary Care Hospital- A Cross-Sectional Study

    Nov 1, 2016, 00:00
  • The Cost-Effectiveness of Blue-Light Therapy Vs Fixed Combination of Calcipotriol and Betamethasone Dipropionate Gel in the Treatment of Mild-To-Moderate Psoriasis

    Nov 1, 2016, 00:00
  • Treatment of Osteochondral Fracture and Medial Patellofemoral Ligament Rupture After Patellar Dislocation

    Nov 1, 2016, 00:00
  • Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in Spain- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00
  • Pegaspargase In The Treatment of Acute Lymphoblastic Leukemia- A CMA Model Demonstrates Its Economic Benefit For The Italian National Health System

    Nov 1, 2016, 00:00
  • The Clinical Value of Olmesartan for the Treatment of Hypertensive Patients- A Systematic Review

    Nov 1, 2016, 00:00
  • Investigating Influenza Vaccinations for Risk Groups in Ukraine

    Nov 1, 2016, 00:00
  • A Review Evaluating the Validity of Motion-Based Gaming Platforms to Measure Clinical Outcomes in Clinical Research

    Nov 1, 2016, 00:00
  • Economic And Humanistic Burden of Chronic Spontaneous Urticaria In Brazil- Impact on Work Productivity, Resource Utilization And Quality of Life

    Nov 1, 2016, 00:00
  • Cost-Effectiveness Of Daclizumab Versus Fingolimod In The Treatment Of Patients With Relapsing-Remitting Multiple Sclerosis In Norway

    Nov 1, 2016, 00:00
  • A Cost-Effectiveness Analysis of Pasireotide Long-Acting Compared To Continued Use of A First-Line Somatostatin Antagonist For The Treatment of Acromegaly In Sweden

    Nov 1, 2016, 00:00
  • Cost Of Lost Productivity Due To Premature, Suicide-Related Mortality In Poland

    Nov 1, 2016, 00:00
  • Automation Of Hospital Medication Distribution Systems In The Us

    Nov 1, 2016, 00:00
  • Timeline of Authorization and Reimbursement for Oncological Drugs in Italy- An Integrated Analysis, Across Legislation’s Leverage

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of D-Dimer in The Diagnosis of Venous Thromboembolism in Colombia

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Treatment of Arm Fractures In Elderly Men And Women – A Systematic Review of The Literature

    Nov 1, 2016, 00:00
  • How To Define Relevant Comparators In France? An Analysis Of The Economic Evaluations Submitted By Manufacturers And Reviewed By The Economic Committee (Ceesp) Of The French National Health Authority

    Nov 1, 2016, 00:00
  • Sensitivity Analysis of Antibiotic Cost in Chronic Suppurative Otitis Media Patients In South India- A Retrospective Observational Study

    Nov 1, 2016, 00:00
  • Burden of Low Vision and Blindness in Chinese Elder Popullation-Data from Field Survey

    Nov 1, 2016, 00:00
  • Impact of Obesity on Patient-Reported Outcomes after Total Knee Replacement

    Nov 1, 2016, 00:00
  • An Observational Study On Helath Related Quality Of Life In Diabetes Mellitus Patients

    Nov 1, 2016, 00:00
  • Incidence of Germline Brca 1 and 2 Mutated Breast Cancer in The EU5

    Nov 1, 2016, 00:00
  • Course of Therapy, Resource Utilization and Costs for The Treatment of Metastatic Colorectal Cancer in Germany

    Nov 1, 2016, 00:00
  • Optimal and Ensure Trials - Based Combined Cost-Effectiveness Analysis of Erlotinib Versus Chemotherapy for the First- Line Treatment of Asian Patients with Nonsquamous Non– Small-Cell Lung Cancer

    Nov 1, 2016, 00:00
  • Linguistic Validation Of The Finnish Version Of The Visual Analogue Scale Foot And Ankle Instrument

    Nov 1, 2016, 00:00
  • The Effect of Depression on Adherence To Hormone Therapy in Breast Cancer Patients

    Nov 1, 2016, 00:00
  • Systematic Review of Eq-5d Based Utility Scores in Leukemias

    Nov 1, 2016, 00:00
  • Application of Payment by Results Schemes in Oncology in Italy- Relation Between Timing for the Evaluation of Treatment Failures and Median Progression Free Survival (PFS) from Clinical Trials

    Nov 1, 2016, 00:00
  • Adapting to the Challenge- How are Innovative Study Designs Being used in Rare Diseases?

    Nov 1, 2016, 00:00
  • Off-Label Use of Ruxolitinib In Refractory Graft-Versus-Host Disease After Allogenic Stem Cell Transplantation

    Nov 1, 2016, 00:00
  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2016, 00:00
  • Productivity Loss In Patients Diagnosed With Spinal Stenosis And Lumbar Disc Herniation

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Edoxaban Compared to Warfarin for The Treatment and Secondary Prevention of Venous Thromboembolism in The UK

    Nov 1, 2016, 00:00
  • Are Drug Procurement Procedure and Award Criteria in EU Hospital Setting Standardized and do they Take into Accounts Effective Supply Quality?

    Nov 1, 2016, 00:00
  • Exploring The Potential Value of Improved Care for Secondary Hyperparathyroidism (SHPT) with A Novel Investigational Calcimimetic Therapy

    Nov 1, 2016, 00:00
  • A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness

    Nov 1, 2016, 00:00
  • Market Access Agreements- What Impacts Drugs Purchasing in French Hospitals

    Nov 1, 2016, 00:00
  • Comparison of Caregiver-Rated 3-Level Euroqol-5d (Eq-5d-3l) and Health Utilities Index Mark 3 (Hui3) in Patients with Dementia in Singapore

    Nov 1, 2016, 00:00
  • GLP-1 Receptor Agonist Treatment-Related Features Important to Type 2 Diabetes Mellitus (T2DM) Patients- A Preference Study in Germany

    Nov 1, 2016, 00:00
  • Ongoing Analysis of Clinical and Economic Outcomes of Japanese Patients with Coronary Heart Disease Undergoing Percutaneous Coronary Intervention

    Nov 1, 2016, 00:00
  • Valuing Health- Results from the Health Auction Valuation Experiment (HAVE) Study

    Nov 1, 2016, 00:00
  • clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients with Atrial Fibrillation

    Nov 1, 2016, 00:00
  • Future Disparities Between Demand And Supply of Tertiary Emergency Care In Regions Affected By The Great East Japan Earthquake

    Nov 1, 2016, 00:00
  • Pro Instruments for Mental Disorders Used in Studies Published Since 2005- Which Diseases have Had The Most Tools Developed?

    Nov 1, 2016, 00:00
  • Cost-Effectiveness Analysis of Sulodexide in Patients with Non-Proliferative Diabetic Retinopathy in the Czech Republic

    Nov 1, 2016, 00:00
  • Taking In Account Research And Development Expenditures To Determine Prices Of Medicines In Fran A Realistic Alternative Choice?

    Nov 1, 2016, 00:00
  • Patient Perspectives on Merkel Cell Carcinoma (MCC) and Its Treatment with A Novel Agent (AVELUMAB)- Findings From In-Depth Qualitative Patient Interviews

    Nov 1, 2016, 00:00
  • A Systematic Review and Meta-Analysis To Access The Efficacy and Safety of Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

    Nov 1, 2016, 00:00
  • Long Term Outcome of Couples Undertaking their First IVF/ICSI Attempt- A French Study

    Nov 1, 2016, 00:00
  • Optimizing COPD Treatment In Portugal – Improving Health Outcomes And Reducing Treatment Costs In Patients with A History of Exacerbation with Indacatrol Plus Glycopyrronium

    Nov 1, 2016, 00:00
  • Understanding Health Technology Assessment (HTA) Bodies in Major Asia-Pacific (APAC) Markets- Systematic Evaluation in 10 APAC Countries

    Nov 1, 2016, 00:00
  • Association Between Insulin Treatment and Breast Cancer Characteristics

    Nov 1, 2016, 00:00
  • Comparison Between the EQ-5D-5l and the EQ-5D-3l for General Population in China

    Nov 1, 2016, 00:00
  • Delayed Access To Bariatric Surgery In Brazil- Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00
  • Current Issues and Future Research Priorities for Health Economic Modelling of at Risk Population for Alzheimer’s Disease/Dementia

    Nov 1, 2016, 00:00
  • Market Uptake Of Direct Oral Anticoagulants (Doacs) In Germany

    Nov 1, 2016, 00:00
  • Risk of Discontinuation of Advanced Therapy Medicinal Products Clinical Trials

    Nov 1, 2016, 00:00
  • Impact of Cardiovascular Outcome Trial (CVOT) Data on EU5 Access for New Type 2 Diabetes Drugs

    Nov 1, 2016, 00:00
  • A Framework To Guide The Use Of Real-World Evidence To Support Evaluation Of Relative Effectiveness Of New Medicines

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Endoscopic Treatment with Radiofrequency Ablation for Patients with Barrett's Esophagus and High Or Low Grade Dysplasia in Spain

    Nov 1, 2016, 00:00
  • A Cprd-Hes Database Study of Back Pain in the UK- Patient Pathways

    Nov 1, 2016, 00:00
  • Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)

    Nov 1, 2016, 00:00
  • A Real-World Evaluation of the Clinical and Economic Burden of United States Veteran Patients with Post-Traumatic Stress Disorder

    Nov 1, 2016, 00:00
  • The German Pain Practice Registry – A New Way to Use Real-Time Sampled Routine Data For Health-Care Research

    Nov 1, 2016, 00:00
  • Health- Related Quality of Life in Diabetic People with Different Cardiovascular Risks

    Nov 1, 2016, 00:00
  • Real World Experience of Sunitinib in Patients with Metastatic Renal Cell Carcinoma; Results from Compassionate use Program in Malaysia

    Nov 1, 2016, 00:00
  • Role of Clinical Pharmacist in Optimizing Reimbursement Originating from Performance-Based Risk-Sharing Arrangements- The Experience of the University Hospital “G. Martino” from Messina, Italy

    Nov 1, 2016, 00:00
  • Efficacy and Safety of Panitumumab in Patients of Metastatic Colorectal Cancer By Tumor Kras Status- A Systematic Review

    Nov 1, 2016, 00:00
  • Association Between Body Mass Index Categories, Prevalence of Treated Type 2 Diabetes Mellitus, Total Healthcare Costs Among Patients Who Are Overweight or Obese

    Nov 1, 2016, 00:00
  • Network Meta-Analysis of Antidiabetic Treatments Added To Insulin Therapy In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00
  • G-BA Early Advice VS. EMA/HTA Parallel Advice from a German Perspective

    Nov 1, 2016, 00:00
  • Generic Drug Volume and Cost Savings in Oncology- A 2005-2014 Midas Analysis

    Nov 1, 2016, 00:00
  • Quality of Life in Relapsing Remmiting Multiple Sclerosis- Influence of Interferon Beta-1a (Avonex And Cinnovex) Treatment

    Nov 1, 2016, 00:00
  • Cadth’s $50,000 Cost-Effectiveness Threshold- Fact or Fiction?

    Nov 1, 2016, 00:00
  • Cost-Effectiveness Analysis of Antihypertensive Drugs Usage by Combination of ACEI – CCB and ACEI – Diuretic in Outpatient Hypertension Therapy at Rsal Mintohardjo Jakarta (July-November 2015)

    Nov 1, 2016, 00:00
  • Association Between Exposure To Anticholinergic And Sedative Drugs And Healthcare Costs In Elderly Patients With Cognitive Complaint

    Nov 1, 2016, 00:00
  • Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

    Nov 1, 2016, 00:00
  • Generalising Results from Cost-Effectiveness Analysis- A Comparison of Methods to Account for Covariates

    Nov 1, 2016, 00:00
  • Comparison of the Trends of Orphan Drugs Designations and Approvals in the United States and Europe In Oncology

    Nov 1, 2016, 00:00
  • Refining The Path to Personalized Medicine with Psychometric Analysis of Oral Cancer Biomarkers

    Nov 1, 2016, 00:00
  • Burden of Early and Advanced Breast Cancer in The Netherlands

    Nov 1, 2016, 00:00
  • Health Care Utilization and Economic Burden of Pancreatic Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00
  • Compare Policies And Research Situation Of Rare Diseases And Orphan Drugs Between China And Other Countries

    Nov 1, 2016, 00:00
  • Treatment Pattern Differences Across the United States, Western Europe, and Japan Among Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00
  • Ticagrelor Treatment for Prevention of Cardiovascular Events in High Risk Post Myocardial Infarction Patients- Cost-Effectiveness Analysis Using Evidence From The Pegasus-Timi 54 Trial

    Nov 1, 2016, 00:00
  • Mapping Transactions from Pharmaceutical Companies to Healthcare Organisations in the EU5

    Nov 1, 2016, 00:00
  • Health Economic Evaluation of HDM Slit-Tablet For Allergen Immunotherapy In House Dust Mite Induced Allergic Rhinitis with or Without Allergic Asthma In An Italian Setting

    Nov 1, 2016, 00:00
  • Patterns of Medication Regimen Complexity Over One-Year Follow Up in Chronic Obstructive Pulmonary Disease Patients

    Nov 1, 2016, 00:00
  • The Impact Of Policy And Demographic Variables On Future Prescription Costs For A Publicly Funded Health Scheme In Ireland

    Nov 1, 2016, 00:00
  • Influence of Medical–Economic Analysis on the Categorization of Special Medical Equipment

    Nov 1, 2016, 00:00
  • Preferences For The Characteristics Of Home Enteral Nutrition (Hen) Via Tube Feeding- A Discrete-Choice Experiment

    Nov 1, 2016, 00:00
  • Cost-Minimization Analysis of Lipegfilgrastim in Prophylaxis Of Febrile Neutropenia in Cancer Patients

    Nov 1, 2016, 00:00
  • Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Definitive Therapy- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00
  • Cost Comparison Of Medical And Surgical Treatments For Medically Intractable Epilepsy

    Nov 1, 2016, 00:00
  • Utilisation of Antithrombotic Drugs in Slovakia

    Nov 1, 2016, 00:00
  • A Systematic Review of Treatment Patterns in Patients with Recurrent Glioblastoma in the Real World

    Nov 1, 2016, 00:00
  • The Burden of Staple Line Interventions in Colorectal Surgery Europe

    Nov 1, 2016, 00:00
  • The use of Alhijama as Complimentary Treatment in Hypertension

    Nov 1, 2016, 00:00
  • Number Of Patients In Physiotherapy Services Within Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00
  • Economic Aspects in the Treatment of Schizophrenia in Italy- Cost Consequences of an Early Long-Acting Injectable Antipsychotics (LAIS) Approach

    Nov 1, 2016, 00:00
  • Screening Rate for Diabetic Retinopathy and Macular Edema in Patients with Diabetes and their Treatment Costs in the United Arab Emirates

    Nov 1, 2016, 00:00
  • Market Regulation May Influence Drug Price Trajectories - A Comparison of Anti Tumor Necrosis Factor Drug Prices In Israel And The USA

    Nov 1, 2016, 00:00
  • Financial Impact of Intraviteal Ranibizumab or Aflibercepte for Neovascular Age-Related Macular Degeneration and for Macular Edema Secondary to Central Retinal Vein Occlusion Coverage for a Health Care System of Public Employees Located in ...

    Nov 1, 2016, 00:00
  • Use of Antihypertensive Medications in Diabetic and Non-Diabetic Chronic Kidney Disease and Hemodialysis Patients- A Due Study

    Nov 1, 2016, 00:00
  • Decision Uncertainty and Need for Further Research- A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic Aneurysms

    Nov 1, 2016, 00:00
  • Incidence Cancer Costs Associated with Head And Neck (HN) Cancers- A Nationwide Study From France In 2008-2013 (EPICORL STUDY)

    Nov 1, 2016, 00:00
  • Economic Impact of Fentanyl HCL Iontophoretic Transdermal System Versus IV PCA In Acute Pain Management Following Surgery In The United Kingdom, Germany And Sweden

    Nov 1, 2016, 00:00
  • A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients with Chronic Hepatitis C Virus Genotype 1 in Iran

    Nov 1, 2016, 00:00
  • Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

    Nov 1, 2016, 00:00
  • Management of Patients with Statin Intoleran Results from a Survey of Clinicians in Six European Countries

    Nov 1, 2016, 00:00
  • Balancing Commercial Confidentiality with Accountability- A Proposal for Enhanced Disclosure of Cost-Effectiveness Decisions

    Nov 1, 2016, 00:00
  • Budget Impact Analysis of Regorafenib for The Treatment in Third and Fourth Lines of Metastasic Colorectal Cancer in Spain

    Nov 1, 2016, 00:00
  • Health Related Quality of Life In The Deaf British Signing Population

    Nov 1, 2016, 00:00
  • Assessment Of Prices Of Essential Medicines For Chronic Diseases Prevalent In The Asia Pacific Region

    Nov 1, 2016, 00:00
  • Evaluation of Attitude and Perception of Retail Pharmacists Towards Patient Safety

    Nov 1, 2016, 00:00
  • Budget Impact Analysis of A Flash Glucose Monitoring System for Patients with Diabetes Who Are Using Intensive Insulin

    Nov 1, 2016, 00:00
  • Trans-Pacific Partnership Agreement And Its Impact On Accessibility And Affordability Of Medicines- A Meta-Synthesis

    Nov 1, 2016, 00:00
  • Automatic Extraction and Classification of Patients’ Smoking Status from Free Text Using Natural Language Processing

    Nov 1, 2016, 00:00
  • Budget Impact Estimation of Changes In Reimbursement of Basal Insulin Therapies in Hungary

    Nov 1, 2016, 00:00
  • Which costs matter? Costs included in economic evaluation and their impact on decision uncertainty- the example of acute myocardial infarction

    Nov 1, 2016, 00:00
  • The Road to Russian Pharmacoeconomics- Understanding the Drivers for Access to High-Value / Orphan Disease Drugs

    Nov 1, 2016, 00:00
  • Literature Review of Studies Evaluating Cost Effectiveness of Prostaglandins and ß-Blockers in Primary Open Angle Glaucoma Patients

    Nov 1, 2016, 00:00
  • Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries

    Nov 1, 2016, 00:00
  • Cost-Effectiveness Analysis of Once-Yearly Injection of Zoledronic Acid For The Treatment of Osteoporosis In Japan

    Nov 1, 2016, 00:00
  • Measuring Of The Uncertainty In Reimbursement System For Medicinal Products

    Nov 1, 2016, 00:00
  • Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece

    Nov 1, 2016, 00:00
  • Mapping the Prescription Trend for Rheumatoid Arthritis in Mumbai, India

    Nov 1, 2016, 00:00
  • Assessing The Potential Cost Saving Potential of Implementing Benepali®, An Etanercept Biosimilar, Using Discount Agreements For The Treatment of All Licensed Etanercept Indications For Adults In Sweden

    Nov 1, 2016, 00:00
  • Cost of Illness Study In Patients With Myasthenia Gravis Treated With Plasma Exchange Therapy In Belgium

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective

    Nov 1, 2016, 00:00
  • Rates And Predictors Of Short Term Disability Claims Among Migraine Patients In The Us

    Nov 1, 2016, 00:00
  • Assessment of Proton Pump Inhibitors Consumption in Ukraine in Comparison with other Countries of The World

    Nov 1, 2016, 00:00
  • The Burden of Severe Asthma in France

    Nov 1, 2016, 00:00
  • Economic Burden of Stroke- A Systematic Review on Post-Stroke Care

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Acupuncture Versus Standard Care For Pelvic And Low Back Pain In Pregnancy- An Analysis of The Game Randomized Trial

    Nov 1, 2016, 00:00
  • Comparative Effectiveness Analysis for Smoking Cessation Medications

    Nov 1, 2016, 00:00
  • How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?

    Nov 1, 2016, 00:00
  • The Patient Journey After A Diagnosis of Early/Locally Advanced Breast CA In Greece And Choice of Provider

    Nov 1, 2016, 00:00
  • Comparative Effectiveness of Targeted Treatments for Pulmonary Arterial Hypertension (PAH) In Patients Receiving Active Treatments without Adequate Response

    Nov 1, 2016, 00:00
  • Global Value Dossiers (GVDS)- How to Ensure the Value Isn’t Lost in Translation

    Nov 1, 2016, 00:00
  • The 2016 US Payor Landscape- Results from a Survey of Medical and Pharmacy Directors on Formulary Management

    Nov 1, 2016, 00:00
  • A Quantitative Analysis of Health Technology Assessment (HTA) Agencies for Attributes Driving Transparency of the Organization- Comparison of Six Asia-Pacific HTA Agencies

    Nov 1, 2016, 00:00
  • Comparative Effectiveness of Platinum Plus Paclitaxel Versus Platinum Plus Cyclophosphamide Among Patients with Early-Stage Ovarian Cancer in Taiwan

    Nov 1, 2016, 00:00
  • Economic Evaluation of First Line Treatment for Advanced Non Small Cell Lung Cancer Using Tyrosine Kinase Inhibitors in Malaysia

    Nov 1, 2016, 00:00
  • Trend in HBA1C Levels Among Primary Care Diabetes Patients Admitted to a Tertiary Hospital in Singapore in 2013

    Nov 1, 2016, 00:00
  • Assessment Of Knowledge And Practice Regarding Foot Care Of Diabetes Mellitus Patient In Tertiary Care Hospitals, Quetta, Pakistan

    Nov 1, 2016, 00:00
  • Directly Eliciting Personal Utility Functions From A Convenience Sample Of 30 Health Outcomes Professionals- A Pilot Study

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Nepafenac 3 Mg/Ml for the Reduction in Risk of Post-Operative Macular Oedema Associated with Cataract Surgery- From UK NHS Perspective

    Nov 1, 2016, 00:00
  • Network Meta-Analysis To Evaluate The Efficacy of Ixekizumab In The Treatment of Moderate-To-Severe Psoriasis

    Nov 1, 2016, 00:00
  • When Cost Saving Technologies are Not Adopted Despite Evidence and Payer Recommendations – Intraoperative Fluid Management (IOFM) in the UK

    Nov 1, 2016, 00:00
  • Oab in Poland - This is Time for A Change

    Nov 1, 2016, 00:00
  • Economic Burden of Primary Immunodeficiency (PIDD) In Turkey

    Nov 1, 2016, 00:00
  • Current Practice and Attitude Regarding off-Label Drug Use- A Survey of Oncology Practitioners

    Nov 1, 2016, 00:00
  • Treatment Cost Estimation of Chronic Gastritis Caused by Helicobacter Pylori

    Nov 1, 2016, 00:00
  • The Impact of Surgical Professional Education- A Review of Clinical and Economic Outcomes

    Nov 1, 2016, 00:00
  • The Use of The Appraisal of Guidelines for Research and Evaluation Ii (AGREE II) Tool for Appraisal of Multiple Myeloma Treatment Guidelines

    Nov 1, 2016, 00:00
  • Hospitalized Patients with Schizophrenia In Portugal- Clinical Characterization and Costs

    Nov 1, 2016, 00:00
  • Real World Data on the Adherance to the National Policy of Integrative and Complementary Practices in the Brazilian Unified Health System - The Acupuncture Case

    Nov 1, 2016, 00:00
  • Heparin and Related Substances for Treating Diabetic Foot Ulcers

    Nov 1, 2016, 00:00
  • Direct Cost Analysis and Cost Effectiveness Analysis of Chronic Obstruction Pulmonary Disease in Fatmawati Public Hospital

    Nov 1, 2016, 00:00
  • The Reduction Of Ceiling With The Eq-5d-5l Increases With Age In The General Adult Population

    Nov 1, 2016, 00:00
  • A Cost of Illness Study Evaluating The Burden of Wolfram Syndrome In The United Kingdom

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Surgical Excision Vs Mohs Micrographic Surgery for Non-Melanoma Skin Cancer

    Nov 1, 2016, 00:00
  • The Organisational Analysis of “Patient Diagnostic Therapeutic Pathway” For Patients with Gastric Cancer In 5 Centres of The Veneto Region (Italy)

    Nov 1, 2016, 00:00
  • Impact of Comorbidities on the Cost of Depression Drug Therapy in General Practices in Germany

    Nov 1, 2016, 00:00
  • Quantification Of Quality Of Life Differences Due To Common Diseases In The Age Group 50+ In The United Kingdom

    Nov 1, 2016, 00:00
  • Understanding the Policy-Relevant Portion of the Efficient Frontier in Screening Interventions- The Importance of Comparator Strategies

    Nov 1, 2016, 00:00
  • A Conceptual Framework for Tackling Market Access Challenges in Asia

    Nov 1, 2016, 00:00
  • Impact of Surgical Technique on Length Of Stay and Early Outcomes in Breast Reconstruction- A Preliminary Analysis

    Nov 1, 2016, 00:00
  • Cost-Utility Analysis of Nivolumab Monotherapy for Metastatic Melanoma Treatment

    Nov 1, 2016, 00:00
  • Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting

    Nov 1, 2016, 00:00
  • Healthcare Resource Utilization in Patients Receiving Pembrolizumab or Docetaxel with Previously Treated Advanced NSCLC

    Nov 1, 2016, 00:00
  • Cost And Cost Per Responder In Spain of Adalimumab, Methotrexate And Apremilast In The Treatment of Methotrexate-Naïve Patients With Psoriatic Arthritis

    Nov 1, 2016, 00:00
  • Management of Children's Acute Diarrhea by Community Pharmacies in Five Towns of Ethiopia- Simulated Client Case

    Nov 1, 2016, 00:00
  • Glatiramer Acetate (Ga) Results in Significant Reductions in Annualized Relapse Rate (Arr) and Protective Effect on Disibiltiy Progression- Results From a Network Meta-Analysis

    Nov 1, 2016, 00:00
  • Knowledge, Attitude and Perception of Japanese Encephalitis Among Healthcare Students of Medicine, Pharmacy and Dentistry of A Private University in Malaysia

    Nov 1, 2016, 00:00
  • Resource use and Associated Costs for Metastatic Squamous Non-Small Cell Lung Cancer (SQ NSCLC) Patients- A Retrospective Chart Review in Select European Countries

    Nov 1, 2016, 00:00
  • Economic Evaluation of Cervical Cancer Screening Strategies in China

    Nov 1, 2016, 00:00
  • Application of A Value Framework Based on Multiple Criteria Decision Analysis in the Context of Health Technology Assessment- A Series of Case Studies with Decision Makers Across European Countries

    Nov 1, 2016, 00:00
  • Pharmacoeconomic Evaluation of Patients Undergoing Hemodialysis At a Tertiary Care Centre

    Nov 1, 2016, 00:00
  • How Assessment Methods May Affect The Efficiency Of Appraisal Process- A Critical Review

    Nov 1, 2016, 00:00
  • The Impact of Pharmacist Intervention on Medication Errors In A Teaching Hospital Quetta, Pakistan

    Nov 1, 2016, 00:00
  • Gestational Diabetes Screening for Chinese Women- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00
  • The Quality-Adjusted Time Without Symptoms and Toxicity (Q-TWIST) in (IMMUNO)-Oncology- A Systematic Review of the Literature

    Nov 1, 2016, 00:00
  • Market Potential Of A New Infliximab Biosimilar In The European Market- A Budget Impact Analysis In France, Italy And The Uk

    Nov 1, 2016, 00:00
  • Cost-Effectiveness Analysis of Sucroferric Oxyhydroxide in Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease

    Nov 1, 2016, 00:00
  • To what Extent are The Learnings from The Introduction of Biosimilars in Inflammatory Diseases Transferable to The Future Introduction of Biosimilars in Oncology?

    Nov 1, 2016, 00:00
  • Healthcare Resource Utilisation And Cost Of Parkinson’s Disease In The United Kingdom

    Nov 1, 2016, 00:00
  • The Economic Burden of Myocardial Infarction in Latin America

    Nov 1, 2016, 00:00
  • Resource Use In Idiopathic Pulmonary Fibrosis- Influence of Disease Progression and Exacerbations

    Nov 1, 2016, 00:00
  • Access To Innovative Medicines In The Czech Republic- Length Of Price And Reimbursement (PR) Procedures

    Nov 1, 2016, 00:00
  • Parametric Simulation of Headache Day Frequency Using A Negative Binomial Distribution- A Case Study of Erenumab in Episodic Migraine

    Nov 1, 2016, 00:00
  • Real World Evidence In Decision-Making Processes On Public Funding Of Drugs In Poland

    Nov 1, 2016, 00:00
  • Assessing The Cost-Utility of Etelcalcetide- A Markov Model

    Nov 1, 2016, 00:00
  • Indirect Costs Genereted By Absenteeism Associated with Sclerosis Multiplex In Poland

    Nov 1, 2016, 00:00
  • Clinico-Economic Evaluation of Combined Treatment of Diabetic Macular Edema

    Nov 1, 2016, 00:00
  • Assessment of Decisions and Cost-Effectiveness Criteria Considered by Seven Health Technology Assessment Agencies

    Nov 1, 2016, 00:00
  • Requirements for Economic Evidence Across Different HTA Bodies

    Nov 1, 2016, 00:00
  • Knowledge and Perception of Medicine, Dentistry and Pharmacy Students of Malaysian University Regarding Ebola Virus Disease (EVD)

    Nov 1, 2016, 00:00
  • Health Resources Use In Patients With Human Immunodeficiency Virus (Hiv) Infection. Real world evidence from italian administrative databases

    Nov 1, 2016, 00:00
  • Attitudes Adherence and Barriers Among Puplicly Employed GPS Towards Evidence Based Medicine and Clinical Practice Guidelines in Cyprus

    Nov 1, 2016, 00:00
  • Macro-Economic Considerations in Healthcare Decision Making

    Nov 1, 2016, 00:00
  • Understanding Methodological Differences Between and The Appropriate Application of Oncology Value Frameworks in Healthcare Decision-Making

    Nov 1, 2016, 00:00
  • Effects of Medical Marijuana Legalization on Marijuana Use Among Adolescents and Adults In The United States

    Nov 1, 2016, 00:00
  • Predictive Validity of National Nosocomial Infection Surveillance (NNIS) and Study on the Efficacy of Nosocomial Infections (SENIC) Risk Indexes for the Incidence of Surgical Site Infections (SSI) in General Surgery at Hospital Universiti S ...

    Nov 1, 2016, 00:00
  • Association Between Subjective Well-Being and Health Status Among the Elderly in China- The Influences of Social Support and Social Adjustment

    Nov 1, 2016, 00:00
  • Medication Adherence And Persistance In Type 2 Diabetes Mellitus (T2dm)- Patients Perspective In Ths Spanish Health Care System

    Nov 1, 2016, 00:00
  • 1) Value of The Clinical Decision Support System For Adverse Drug Event Prevention- A Cost-Effectiveness Analysis And Cost-Benefit Analysis

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Paritaprevir/Rotanavir/Ombitasvir with or without Dasabuvir in Ireland

    Nov 1, 2016, 00:00
  • Assessing Health-Utility Values for Chronic Spontaneous/Idiopathic Urticaria In Real-World Using The EQ-5D- Results From Assure-Csu Study

    Nov 1, 2016, 00:00
  • Humanistic and Economic Outcomes of Pharmacist-Provided Medication Reviews in the Elderly- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00
  • Indirect Comparison of Triamcinolone Acetonide with Ranibizumab and Aflibercept for the Treatment of Diabetic Macular Edema

    Nov 1, 2016, 00:00
  • Economic Burden of Diseases In Poland

    Nov 1, 2016, 00:00
  • Value of Individually Prepared Drugs for Health System

    Nov 1, 2016, 00:00
  • Burden of Illness in Patients with Elevated High-Sensitivity C-Reactive Protein Levels and a History of Myocardial Infarction- A Targeted Literature Review

    Nov 1, 2016, 00:00
  • Primary Non-Adherence, Early Non-Persistence, Treatment Reinitiation and Long-Term Adherence Among A Population-Based Cohort of Naïve Patients Prescribed Antiosteoporotics

    Nov 1, 2016, 00:00
  • Development, Validation, and Pilot Testing of Metabolic Syndrome Quality of Life Questionnaire (Tapmetsqol)

    Nov 1, 2016, 00:00
  • Drug Utilization Evaluation Study of Sildenafil in a Tertiary Care Teaching Hospital in India – A Retrospective Analysis

    Nov 1, 2016, 00:00
  • Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan

    Nov 1, 2016, 00:00
  • Patient Characteristics And Outcomes Of Hospitalization For Influenza Infection In Hong Kong

    Nov 1, 2016, 00:00
  • Health Economic Costing Methods and Reporting in Austria

    Nov 1, 2016, 00:00
  • Analysis of Pharmacy Claims for High Cost Oncology Products- Abiraterone and Enzalutamide Usage in Mcrpc in Ireland

    Nov 1, 2016, 00:00
  • Cost And Resource Utilization Among Multiple Sclerosis Patients With Increasing Disability In Latin America

    Nov 1, 2016, 00:00
  • Insulin Degludec in Clinical Practi A Systematic Review of Japanese Real-World Data

    Nov 1, 2016, 00:00
  • French Health Policies- Front Runner for Early Access to Innovation

    Nov 1, 2016, 00:00
  • Reconsidering EQ-5D; Quality of Life Domains that are Important for Multiple Sclerosis Patients

    Nov 1, 2016, 00:00
  • The Impact of Inflammatory Bowel Disease on Work Productivity- Comparison of A Real-World Sample Of Patients With Crohn's Disease And Ulcerative Colitis

    Nov 1, 2016, 00:00
  • Systematic Review of Budget Impact Analysis on Vaccines

    Nov 1, 2016, 00:00
  • Translatability Evaluation of the Rome IV Diagnostic Questionnaire for Adults

    Nov 1, 2016, 00:00
  • Supplementing the Right Way- Effective Cost Management of Multivitamin Syrups in a Paediatric Hospital

    Nov 1, 2016, 00:00
  • Using A Smartphone Based Self-Management Platform To Support Medication Adherence And Clinical Consultation In Parkinson’s Disease Results From The Smart-PD Randomised Controlled Trial

    Nov 1, 2016, 00:00
  • Using Social Finance to Fund Generic Drug Repurposing for Rare Diseases- A Social Impact Bond Proof of Concept

    Nov 1, 2016, 00:00
  • Review of National Health Technology Assessment Reports on Treatment of Severe Haemophilia A

    Nov 1, 2016, 00:00
  • Cyproterone/Ethinylestradiol and Concomitant Use of other Hormonal Contraceptives in the Netherlands

    Nov 1, 2016, 00:00
  • Cholesterol Management in the US

    Nov 1, 2016, 00:00
  • Efficacy of Palbociclib Combinations Versus Endocrine Therapies in Advanced/ Metastatic Breast Cancer- Network Meta-Analysis

    Nov 1, 2016, 00:00
  • High-Risk Medications and Unplanned Hospitalizations- A Case–Time–Control Study

    Nov 1, 2016, 00:00
  • Drug Utilization in an Outpatient Private Paediatric Setting- An Observational Study

    Nov 1, 2016, 00:00
  • Facing Challenges for a Cost Comparison of Day Surgical and Inpatient Varicose Vein Surgery

    Nov 1, 2016, 00:00
  • Assessment Of Core Drug Use Indicators Using Who/Inrud Methodology At Primary Health Care Centers In Bahawalpur, Pakistan

    Nov 1, 2016, 00:00
  • New Approach to Budget Impact Analysis - Ibrutinib In Treatment of Relapsed/Refractory Cll Patients in The Czech Republic

    Nov 1, 2016, 00:00
  • A Budget Impact Analysis of The Introduction of Generic Bosentan For The Treatment of Pulmonary Arterial Hypertension In Greece

    Nov 1, 2016, 00:00
  • Cost-Effectiveness of Granulocyte Colony-Stimulating Factor (G-Csf) as Adjunctive Therapy in Cancer Patients with Established Febrile Neutropenia

    Nov 1, 2016, 00:00
  • Adherence to Oral Antidiabetic Medication in Type 2 Diabetes Mellitus Clients in the Volta Region of Ghana

    Nov 1, 2016, 00:00
  • Analyzing a German Index for the EQ-5D-5L Based on Experienced Health

    Nov 1, 2016, 00:00
  • Clinical And Economic Outcomes Of Pharmacist Intervention During Therapeutic Drug Monitoring Program In Saudi Arabia

    Nov 1, 2016, 00:00
  • Will Stem Cells For Heart Failure Be The Next Sofosbuvir Issue?

    Nov 1, 2016, 00:00
  • Market Access Routes for Orphan Oncology Drugs- How do Health Systems Help Patients Receive Treatments that are not Cost-Effective?

    Nov 1, 2016, 00:00
  • Linguistic Validation and Electronic Migration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)

    Nov 1, 2016, 00:00
  • Capacity for Endoscopic Screening for Gastric Cancer in Japan

    Nov 1, 2016, 00:00
  • Biosimilar Infliximab- Feedback After A Nine Months Experience Of Their Use In The 37 Public Hospitals Of Paris

    Nov 1, 2016, 00:00
  • From The Unified Parkinson’s Disease Rating Scale (UPDRS) To The EQ-5D Utility Index- Development of A New Mapping Algorithm In Parkinson’s Disease (PD)

    Nov 1, 2016, 00:00
  • Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm)

    Nov 1, 2016, 00:00
  • Health State Utilities Associated with Post-Surgical Staphylococcus Aureus Infection

    Nov 1, 2016, 00:00
  • Utilization And Cost Of Antimicrobials Used In Medicine And Surgery Departments Of A Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00
  • Resource Utilization and Costs Associated with the Investigation of Pulmonary Nodules in Quebec, Canada

    Nov 1, 2016, 00:00
  • Cardiovascular Event Rates in Patients with High Cardiovascular Risk in the United Kingdom

    Nov 1, 2016, 00:00
  • What's New in the Guidelines for Submission of Dossier for Listing into the Ministry of Health Medicines Formulary (Mohmf) ?

    Nov 1, 2016, 00:00
  • Launching Novel Antibiotics- Access Opportunities and Resistance in European Markets

    Nov 1, 2016, 00:00
  • Predictors of Response to Interferone/Ribavarin Combination Therapy in Chronic Hepatitis C Virus Infection at Upper Egypt

    Nov 1, 2016, 00:00
  • Oncologists` Views on Reimbursement and Value of Cancer Drugs in Bosnia and Herzegovina

    Nov 1, 2016, 00:00
  • Comparison of Methods to Assess the Relative Importance of Criteria in Multi-Criteria Decision Analysis- An Evaluation of Orphan Drugs in Russia

    Nov 1, 2016, 00:00
  • Treatment Comparative Effectiveness In Rare Diseases- The Case of Transthyretin Familial Amyloid Polyneuropathy Survival

    Nov 1, 2016, 00:00
  • Improvements in Productivity at Paid Work and Within the Household, and Increased Participation in Daily Activities Over 52 Weeks of Certolizumab Pegol Treatment of Rheumatoid Arthritis- Results of A Belgian Observational Non-Interventional ...

    Nov 1, 2016, 00:00
  • Gefitinib, Erlotinib or Afatinib for EGFR Mutated NSCLC patients? A Meta-Analysis and Indirect Comparison on the Efficacy of First-Line Tyrosine Kinase Inhibitors

    Nov 1, 2016, 00:00
  • A Systematic Review of The SF-36® Health Survey for Measuring Health-Related Quality of Life In Patients with Ulcerative Colitis

    Nov 1, 2016, 00:00
  • Burden of Diverticular Disease- An Observational Analysis Based on Italian Real World Data

    Nov 1, 2016, 00:00
  • Comorbidity of Depression And Type 2 Diabetes- A Retrospective Japanese Claims Database Analysis

    Nov 1, 2016, 00:00
  • Empirical Assessment of the Impact of Model Choice (Markov State Transition Versus Partitioned Survival) in Modelling Small-Cell Lung Cancer

    Nov 1, 2016, 00:00
  • Drug Utilisation of Braf Inhibitors for Melanoma in Ireland

    Nov 1, 2016, 00:00
  • An Update of Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cells Transplant Patients

    Nov 1, 2016, 00:00
  • The Prevalence of Nosocomial Infections in Karaganda (Kazakhstan) During 2011-2015

    Nov 1, 2016, 00:00
  • Multimorbidity and Health Care Service Utilization in the Australian Workfor Findings From the National Health Survey

    Nov 1, 2016, 00:00
  • Self-Care Behavior And Medication Use Of Buddhist Monks With Diabetes Mellitus In Phasi Charoen, Bangkok

    Nov 1, 2016, 00:00
  • A Systematic Review On The Epidemiology of NRAS-Mutant Melanoma in Europe and Australia

    Nov 1, 2016, 00:00
  • Health-Related Quality of Life of Users of Primary Care in Brazil

    Nov 1, 2016, 00:00
  • Long-Term Health Care Cost in Patients with Symptomatic Peripheral Artery Disease- Results from a Swedish Nationwide Study

    Nov 1, 2016, 00:00
  • Caesarean Section In Xindu County of Chengdu, China- Trend And Its Correlates From 2008 to 2014

    Nov 1, 2016, 00:00
  • Characteristics Of A Patient Population Recruited Using Social Media (Facebook) Compared With Newspaper Advertising (Daily Mail)

    Nov 1, 2016, 00:00
  • Impact of Trial Design on Price Discounts after Early Benefit Assessment (AMNOG) in Germany

    Nov 1, 2016, 00:00
  • Psychometric Evaluation Of The Revised Hiv Treatment Satisfaction Questionnaire (Hivtsq)

    Nov 1, 2016, 00:00
  • The Current Status And Influential Factors of Insulin Pen Needle Reuse In T2D Patients From China

    Nov 1, 2016, 00:00
  • The Role and Impact of Evidence Review Group Analyses in the Nice Single Technology Assessment (STA) Process

    Nov 1, 2016, 00:00
  • Disease Related Knowledge, Medication Adherence And Glycaemic Control Among Patients With Type 2 Diabetes Mellitus In Pakistan

    Nov 1, 2016, 00:00
  • Faecal Calprotectin as A Diagnostic Marker of Inflammatory Bowel Disease in Patients with Gastrointestinal Symptoms - is It Cost-Effective Procedure in Primary Care in Poland?

    Nov 1, 2016, 00:00
  • The Social Cost of Major Depression

    Nov 1, 2016, 00:00
  • Budgetary Impact Analysis of Reimbursement Varenicline in the Smoking Cessation Treatment of Patients with Major Depression in Spain

    Nov 1, 2016, 00:00
  • Do Pharmaceutical Cost Control Policies Effective In Reducing Pharmaceutical Expenditure And Volume? A Systematic Review

    Nov 1, 2016, 00:00
  • Expert Elicitation- Can Variation In Elicited Distributions Be Explained By Expert Heterogeneity?

    Nov 1, 2016, 00:00
  • Cost Burden of Crohn's Disease and Ulcerative Colitis in the United States

    Nov 1, 2016, 00:00
  • Patterns of Index Biologic Drug Registrations To A Pharmacovigilance Register of Psoriasis Patients

    Nov 1, 2016, 00:00
  • Budget Impact Analysis of Panobinostat – Bortezomib and Dexamethasone, As 3rd Or 4th Line of Treatment in Patients with Relapsed/Refractory Multiple Myeloma in Greece

    Nov 1, 2016, 00:00
  • Economic Evaluations of Haemophilus Influenzae Type B Vaccine- A Systematic Review

    Nov 1, 2016, 00:00
  • Burden Of Comorbidities In Hcv And Hiv/Hcv Patients. Real world evidence from italian administrative databases

    Nov 1, 2016, 00:00
  • HCV- Treat Ratio and Governance Footprints. Analysis of Regional Differences in Italy

    Nov 1, 2016, 00:00
  • Effectiveness and Safety of Vemurafenib as Monotherapy in Unresectable or Metastatic Melanoma from an Academic Database- Real World Data to Strengthen Evidence for Payer

    Nov 1, 2016, 00:00
  • Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85 (current)
  • 86
  • 87
  • 88
  • 89
  • 90
  • »